Keyphrases
Visual Acuity
100%
Intravitreal Injection
98%
Age-related Macular Degeneration
70%
Intravitreal Ranibizumab
70%
Pars Plana Vitrectomy
64%
Vitrectomy
61%
Bevacizumab
60%
Diabetic Macular Edema
50%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
50%
Rhegmatogenous Retinal Detachment
42%
Intraocular Pressure
36%
Best-corrected Visual Acuity
33%
Macular Hole
33%
Ozurdex
32%
Most Cited Papers
32%
Intravitreal
32%
Macular Edema
31%
Ophthalmologist
31%
Ranibizumab
30%
Ophthalmology
29%
Intravitreal Administration
28%
Syrinx
28%
Magnetic Resonance Imaging
27%
Subretinal Fluid
27%
Retinal Thickness
27%
Retinal Detachment
27%
Retina
26%
Optical Coherence Tomography
26%
Epiretinal Membrane
26%
Visual Prognosis
26%
Retinal Vein Occlusion
25%
Central Macular Thickness
24%
Neovascular Age-related Macular Degeneration (nAMD)
24%
Computed Tomography
24%
Laser Retinopexy
24%
Cataract Extraction
23%
Diabetic Retinopathy
23%
Retinal Diseases
23%
Anti-VEGF Therapy
20%
Topical Bevacizumab
20%
Drug Delivery
20%
Choroidal Thickness
19%
Elderly Patients
18%
Young Patients
18%
Intraocular Pressure Reduction
17%
Non-metallic
17%
Response to Treatment
16%
Scleral Buckle
16%
Timolol
16%
Operative
16%
Medicine and Dentistry
Visual Acuity
99%
Intravitreal Administration
93%
Optical Coherence Tomography
83%
Vitrectomy
81%
Retinal Detachment
80%
Bevacizumab
64%
Pars Plana Vitrectomy
57%
Macular Hole
56%
Dexamethasone
48%
Epiretinal Membrane
46%
Age Related Macular Degeneration
46%
Vasculotropin
45%
Best Corrected Visual Acuity
35%
Macular Edema
33%
Diabetic Macular Edema
32%
Retinopexy
32%
Cataract Surgery
30%
Retina Disease
29%
Ophthalmology
28%
Retrospective Study
26%
Intraocular Pressure
24%
Magnetic Resonance Imaging
24%
Elderly Patient
24%
Surgical Technique
23%
Visual Impairment
22%
Subretinal Fluid
21%
Choroid
21%
Anterior Chamber of Eyeball
19%
Refractive Error
18%
Maculopathy
18%
Endophthalmitis
18%
Retina Tear
18%
Cataract
18%
Silicone Oil
17%
Uveitis
16%
Sclera
16%
Scleral Buckle
16%
Computer Assisted Tomography
16%
Choroidal Neovascularization
16%
Eye Injury
16%
Wet Macular Degeneration
16%
Endothelial Cell Growth Factor
16%
Retina Vein Occlusion
16%
Stem Cell
15%
Glaucoma
15%
Cell Therapy
14%
Diabetic Retinopathy
14%
Clinical Trial
14%
Hematopoietic Cell
14%
Awareness
14%